Varikuti Sanjay, Jha Bijay Kumar, Volpedo Greta, Ryan Nathan M, Halsey Gregory, Hamza Omar M, McGwire Bradford S, Satoskar Abhay R
Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Front Microbiol. 2018 Nov 30;9:2655. doi: 10.3389/fmicb.2018.02655. eCollection 2018.
The neglected tropical diseases (NTDs) caused by protozoan parasites are responsible for significant morbidity and mortality worldwide. Current treatments using anti-parasitic drugs are toxic and prolonged with poor patient compliance. In addition, emergence of drug-resistant parasites is increasing worldwide. Hence, there is a need for safer and better therapeutics for these infections. Host-directed therapy using drugs that target host pathways required for pathogen survival or its clearance is a promising approach for treating infections. This review will give a summary of the current status and advances of host-targeted therapies for treating NTDs caused by protozoa.
由原生动物寄生虫引起的被忽视热带病(NTDs)在全球范围内导致了严重的发病和死亡。目前使用抗寄生虫药物的治疗方法有毒性且疗程长,患者依从性差。此外,耐药寄生虫在全球范围内不断出现。因此,需要更安全、更好的疗法来治疗这些感染。使用针对病原体生存或清除所需宿主途径的药物进行宿主导向疗法是治疗感染的一种有前景的方法。本综述将总结针对原生动物引起的被忽视热带病进行宿主靶向治疗的现状和进展。